Michael Goodman, University of Cincinnati (IMAGE)

University of Cincinnati

Michael Goodman, University of Cincinnati

Caption

Michael Goodman, MD, leads the team of University of Cincinnati researchers hoping to determine the role sphingolipids play in the formation of microparticles and the development of blood clots, and whether they can be targeted with existing or new anticoagulants.

Credit

University of Cincinnati

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.